Zai Lab Limited
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $106.3M | $99.6M | $127.6M | $116.1M | $110.0M | $106.5M | $109.1M | $102.3M |
| Cost of Revenue | $48.2M | $38.3M | $62.3M | $46.8M | $43.0M | $38.5M | $41.8M | $36.6M |
| Gross Profit | $58.1M | $61.3M | $65.3M | $69.3M | $67.0M | $68.0M | $67.3M | $65.7M |
| Gross Margin | 54.7% | 61.5% | 51.2% | 59.7% | 60.9% | 63.9% | 61.7% | 64.2% |
| Operating Expenses | ||||||||
| Research & Development | $61.8M | $65.6M | $61.6M | $47.9M | $50.6M | $60.7M | $52.3M | $66.0M |
| SG&A Expense | $72.9M | $65.1M | $73.0M | $70.1M | $71.0M | $63.4M | $82.6M | $67.2M |
| Operating Income | $-76.5M | $-69.4M | $-69.4M | $-48.8M | $-54.9M | $-56.3M | $-67.9M | $-67.9M |
| Operating Margin | -71.9% | -69.7% | -54.4% | -42.1% | -49.9% | -52.9% | -62.2% | -66.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-51.8M | $-49.6M | $-53.3M | $-36.0M | $-40.7M | $-48.4M | $-81.7M | $-41.7M |
| Income Tax Expense | $-1.0M | $1.4M | $-2.9M | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-50.8M | $-51.0M | $-50.4M | $-36.0M | $-40.7M | $-48.4M | $-81.7M | $-41.7M |
| Net Margin | -47.8% | -51.2% | -39.5% | -31.0% | -37.0% | -45.5% | -74.9% | -40.7% |
| EPS (Basic) | $-0.05 | $-0.05 | $-0.05 | $-0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.04 |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.05 | $-0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.04 |
| Shares Outstanding (Basic) | 1.12B | 1.11B | 1.10B | 1.10B | 1.09B | 1.08B | 989.5M | 981.7M |
| Shares Outstanding (Diluted) | 1.12B | 1.11B | 1.10B | 1.10B | 1.09B | 1.08B | 989.5M | 981.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |